Association of nirmatrelvir/ritonavir treatment on upper respiratory SARS-CoV-2 RT-PCR negative conversion rates among high-risk patients with COVID-19
Li et al., Clinical Infectious Diseases, doi:10.1093/cid/ciac600
https://c19early.org/li16.html